In this below table we have collated data of 200+ industries from the IRS database in a condensed format. Out stock . These ratios are derived by dividing one financial measurement by the other. | Browse . %Non-Cash Expenses / Net Sales is a measure of the companys non-cash expenses to sales. This means that the company has enough assets to liquidate and pay off their current liabilities instantly. Dollars. Current and historical current ratio for Teva Pharmaceutical Industries (TEVA) from 2010 to 2022. jeep grand cherokee under $18,000. Companies generally use certain guidelines to derive multiples. Further, to get the account receivables turnover in days, divide 365 by the accounts receivable turnover ratio. The curation of data over 10 years makes it a go-to document for in-depth industry trends. Current Industry PE. realspace keri 48"w writing desk; sysco warehouse order selector schedule; The expected growth of the global pharmaceuticals market in 2020 is $1228.45 billion, with 2021 reaching $1250.24 billion. Your inventory turnover ratio (ITR) is the number of times you sell all your inventory over a given period (such as a year). Return On Tangible Equity. The price-to-research ratio is calculated by dividing a company's market value by its last 12 months of expenditures on research and development. Quick ratio, also called the acid-test ratio, indicates the dollar amount of liquid assets available against the dollar amount of the companys current liabilities. We are happy to help you with everything and also offer free training. In this article, we will explore the idea of financial ratios with a deeper insight into some of the basic types of ratios. Scores higher than 1 indicates good health of the companys debt scenario. Our expert team of analysts at Eqvista can support you through this process. Brazil was the South American country with the largest pharmaceutical market value at nearly 21 Billion U.S. dollars in 2020. Check your inbox or spam folder to confirm your subscription. New York City, NY 10170. One of the leading players in the industry, Johnson & Johnson, has reported sales of $23.3bn in the third quarter of 2021, a rise of 10.7% compared to $21.08bn in the same quarter in 2020. . Saudi Arabia has the largest manufacturing industry in the Gulf. This cookie is set by GDPR Cookie Consent plugin. Once a pharmaceutical company manages to bring a product to market, a key element is how the company can manufacture and sell the product. The price-to-research ratio measures the relationship between a company's market capitalization and its research and development expenses. Population aging, pricing pressures and greater expectations from more people The industry is trading close to its 3-year average PS ratio of 4.3x. Cipla has showed highest current ratio in 2012. Teva Pharmaceutical Industries current ratio for the three months ending December 31, 2022 was. The Current P/B Ratio of SUN PHARMACEUTICAL INDUSTRIES is 4.82. Pharmaceutical companies have been top performers in the healthcare sector in an era of aging populations, rising healthcare costs, and the ongoing development of new and extremely profitable medicines. Pharmaceutical companies are characterized by high capital expenditures on research and development (R&D) and a long period between initial research and finally getting a product to market. We have provided a few examples below that you can copy and paste to your site: Your data export is now complete. .a{fill:#6db41e;stroke:#637733;}.b,.d{fill:none;}.b{stroke:#fff;}.c{stroke:none;}, BSE: 511042 | NSE: | Home > PS Ratio > SUN PHARMACEUTICAL INDUSTRIES . if(typeof(wpDataCharts)=='undefined'){wpDataCharts = {};}; wpDataCharts[526] = {render_data: {"options":{"title":{"text":"Top Global Pharmaceutical Companies Based on Pharma Revenue 2021","floating":false,"align":"center"},"series":[{"type":"","name":"Pfizer","color":"","label":"Pfizer","orig_header":"pfizer","data":[81300],"yAxis":0},{"type":"","name":"Roche","color":"","label":"Roche","orig_header":"roche","data":[68100],"yAxis":0},{"type":"","name":"AbbVie","color":"","label":"AbbVie","orig_header":"abbvie","data":[56100],"yAxis":0},{"type":"","name":"Johnson & Johnson","color":"","label":"Johnson & Johnson","orig_header":"johnsonjohnson","data":[52100],"yAxis":0},{"type":"","name":"Novartis","color":"","label":"Novartis","orig_header":"novartis","data":[51600],"yAxis":0},{"type":"","name":"Merck & Co.","color":"","label":"Merck & Co.","orig_header":"merckco","data":[48700],"yAxis":0},{"type":"","name":"Bristol-Myers Squibb","color":"","label":"Bristol-Myers Squibb","orig_header":"bristolmyerssquibb","data":[46400],"yAxis":0},{"type":"","name":"GlaxoSmithKline","color":"","label":"GlaxoSmithKline","orig_header":"glaxosmithkline","data":[46100],"yAxis":0},{"type":"","name":"Sanofi","color":"","label":"Sanofi","orig_header":"sanofi","data":[42900],"yAxis":0}],"xAxis":{"categories":["Company"],"crosshair":false},"yAxis":[{"gridLineDashStyle":"solid","title":{"text":"Reveneu (In million US$)"},"crosshair":false},[],[],[],[],[],[],[],[]],"chart":{"backgroundColor":"","borderWidth":0,"borderColor":"","borderRadius":0,"zoomType":"none","panning":false,"panKey":"shift","plotBackgroundColor":"","plotBackgroundImage":"","plotBorderColor":"","plotBorderWidth":"","inverted":false},"subtitle":{"text":"","align":"center"},"tooltip":{"enabled":true,"backgroundColor":"rgba(255, 255, 255, 0.85)","borderWidth":"1","borderColor":"","borderRadius":3,"shared":false,"valuePrefix":"","valueSuffix":""},"legend":{"enabled":true,"backgroundColor":"","title":{"text":""},"layout":"horizontal","align":"center","verticalAlign":"bottom","borderWidth":"0","borderColor":"","borderRadius":"0"},"exporting":{"enabled":false,"chartOptions":{"plotOptions":{"series":{"dataLabels":{"enabled":false}}}},"filename":"","width":"","buttons":{"contextButton":{"align":"right","verticalAlign":"top","symbolStroke":"#666","text":""}}},"credits":{"enabled":true,"href":"https:\/\/market.us\/","text":"\u00a9 Market.us 2022"}},"type":"highcharts_basic_column_chart","height":"400"}, engine: "highcharts", type: "highcharts_basic_column_chart", title: "Top Global Pharmaceutical Companies Based on Pharma Revenue 2021", container: "wpDataChart_526", follow_filtering: 0, wpdatatable_id: 619, group_chart: 0}. Please check your download folder. Pharmaceutical Preparations: average industry financial ratios for U.S. listed companies Industry: 2834 - Pharmaceutical Preparations Measure of center: median (recommended) average Financial ratio However, considering a stand-alone ratio can be misleading. A further 70 cents is being produced in Latin America for every dollar made by the pharmaceutical industry. It seems we cant find what youre looking for. The annual revenue of Bayer AG is US$ 47.09 billion in the year 2021. Pharmaceutical companies are characterized by high capital expenditures on research and development (R&D) and a long period between initial research and finally getting a product to market. Directly accessible data for 170 industries from 50 countries and over 1 million facts: Get quick analyses with our professional research service. ROI. We have also compiled a comprehensive database of the IRS financial ratios by industry which will act as quick reference for your respective businesses. In comparison, the quick ratio is far more conservative than the current ratio which accounts for only the current assets. Calculation: Current Assets / Current Liabilities. ideal current ratio for pharmaceutical industry. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. .a{fill:#6db41e;stroke:#637733;}.b,.d{fill:none;}.b{stroke:#fff;}.c{stroke:none;}, +899.62 (+1.53%) Quick Ratio This ratio is sometimes known as Acid Test or Liquidity Ratio.lt is 1 Return on Research Capital Ratio. These cookies ensure basic functionalities and security features of the website, anonymously. Current and historical current ratio for Teva Pharmaceutical Industries (TEVA) from 2010 to 2022. Current and historical current ratio for Pfizer (PFE) from 2010 to 2022. Cipla has showed highest current ratio in 2012. Current ratio 20-21 4.1.2. Cleveland Browns Scouting Jobs, Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet. Though a higher payable turnover ratio indicates the creditworthiness of a company, the company must strive towards favorable credit terms with their suppliers so that they do not have to make hurried and frequent payments, in which they run the risk of penalties. If you use our datasets on your site or blog, we ask that you provide attribution via a "dofollow" link back to this page. Among top pharmaceutical companies in 2021, Novo Nordisk had the highest gross margin, followed by Biogen and Gilead Sciences. However as is the case with all financial ratios, a company should compare their ratio with their competitors and industry standards to make sense of best practices suited for their business. mcmarketstockprice->Moneycontrol/MC_Market/MC_Market_StockPrice_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250|~|Moneycontrol/MC_Market/MC_Market_StockPrice_728x90_2|~|Moneycontrol/MC_Market/MC_Market_StockPrice_728x90_1|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_2|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_1|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250_BTF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_BTF|~|Moneycontrol/MC_Market/MC_Market_StockPrice_300x250/MC_Market_StockPrice_Notices_300x250_ATF|~|Moneycontrol/MC_Market/MC_Market_StockPrice_QuartResult_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_CapitalStruc_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_PriceChart_728x90|~|Moneycontrol/MC_Market/MC_Market_StockPrice_History_300x600_ATF|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_ATF_1|~|Moneycontrol/MC_PriceChart/MC_PriceChart_728x90_ATF_1|~|Moneycontrol/MC_PriceChart/MC_PriceChart_300x250_MTF->, Standard Medical Pharmaceuticals is not listed on BSE, Standard Medical Pharmaceuticals is not listed on NSE, Invest in high-rated bonds from as low as Rs. The company should find a good balance between enough compensation for the hard work of the officers and having enough working capital for the company to grow at a steady rate. Numbers change as more businesses report financial results. Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Bayer is the 4th most profitable pharmaceutical company globally. Series: NA | Within Healthcare sector 4 other industries have achieved higher Working Capital Ratio. Teva Pharmaceutical Industries current ratio for the three months ending December 31, 2022 was 1.05. TEVA Current Ratio as of today (June 12, 2022) is 1.07. On the trailing twelve months basis Current Liabilities decreased faster than Industry's Current Assets, this led to improvement in Industry's Working Capital Ratio to 1.77 in the 3 Q 2019, Working Capital Ratio remained below Major Pharmaceutical Preparations Industry average. If this is the case, the company has more than enough cash to meet its liabilities while using its capital effectively. Transforme seu WhatsApp em uma poderosa mquina de vendas % Off. french open tsitsipas woolworths shareholder equity. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Home > PE Ratio > SUN PHARMACEUTICAL INDUSTRIES . The quick ratio is a financial metric used to measure short-term liquidity. The current ratio weighs up all of a company's current assets to its current. The pharmaceutical industry is facing many challenges. These emerging markets are the ones that see the most significant increase in pharmaceutical sales. With the global pharmaceutical market valued at over one trillion dollars, it is a large industry. All companies havent been maintaining ideal current ratio except Sunpharma. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc. Pharmaceutical companies are characterized by high capital expenditures, such as the amount that must be spent on R&D to create new drugs. With revenue increase of 4.27% in 4 Q 2022 year on year, revenue per employee for Biotechnology & Pharmaceuticals Industry grew on trailing twelve months basis to 997,180 $, above Biotechnology & Pharmaceuticals Industry average. This cookie is set by GDPR Cookie Consent plugin. 1. ideal current ratio for pharmaceutical industry. Cash Ratio 23 . Financial ratios are primarily used by two categories of people: Of the many financial ratios used, this section provides a snapshot of the four basic ones. These cookies will be stored in your browser only with your consent. Working Capital Ratio total ranking has deteriorated relative to the New CE data from 20092010 will become. It includes the compound annual growth rate, as well as regional submarkets. Despite the increasing global revenues, Latin American regions account for the lowest proportion of the global pharmaceutical market revenues. ideal current ratio for pharmaceutical industry. Number of U.S. listed companies included in the calculation: 4190 (year 2021) Ratio: Current Ratio Measure of center: Explore now . It is otherwise also known as estimated price to earnings . A higher ratio automatically indicates the companys strong financial position, attracting more investors. The best way to use this ratio is to compare the companys present ratio to its historical ratio as well as the one of competitors and industry average. Investors use this ratio to monitor a companys usage of assets for revenue generation. ROI. Miscellaneous Fabricated Products Industry, Industrial Machinery and Components Industry, Renewable Energy Services & Equipment Industry, Miscellaneous Financial Services Industry, Laboratory Analytical Instruments Industry, In Vitro & In Vivo Diagnostic Substances Industry, Print Media & Newspaper Publishing Industry, Computer Peripherals & Office Equipment Industry, Internet Services & Social Media Industry, Electronic Instruments & Controls Industry, Computer processing and cloud services Industry, Scientific & Technical Instruments Industry, Internet, Mail Order & Online Shops Industry, Pharmacy Services & Retail Drugstore Industry, More Major Pharmaceutical Preparations Industrys' historic efficiency information >>, Compare Industry's Sales per Employee to 's or S&P, More Data About Major Pharmaceutical Preparations Industry, Revenue per Employee for CLOV's Competitors, Compare Industry's Income per Employee to 's or S&P, Income per Employee for CLOV's Competitors, Compare Industry's Receivable Turnover to 's or S&P, Receivable Turnover for CLOV's Competitors, Compare Industry's Inventory Turnover to 's or S&P, Inventory Turnover for CLOV's Competitors, Compare Industry's Asset Turnover to 's or S&P. Please check your download folder. Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors. This report advises NVS to pursue more market acquisition strategies in emerging markets. That being said, how good a current ratio is In the export side of the world pharmaceutical market concentration ratios of 14.68%, 45.64%, 73.79%, and 90.37% were obtained for the 1, 4, 8, and 16 firm respectively for 2001-2012. . UK)","Africa","Middle East","Southeast & East Asia","China","EU","North America","Oceania","Japan"],"crosshair":false},"yAxis":[{"gridLineDashStyle":"solid","title":{"text":"Market Growth in %"},"crosshair":false}],"chart":{"backgroundColor":"","borderWidth":0,"borderColor":"","borderRadius":0,"zoomType":"none","panning":false,"panKey":"shift","plotBackgroundColor":"","plotBackgroundImage":"","plotBorderColor":"","plotBorderWidth":"","inverted":false},"subtitle":{"text":"","align":"center"},"tooltip":{"enabled":true,"backgroundColor":"rgba(255, 255, 255, 0.85)","borderWidth":"1","borderColor":"","borderRadius":3,"shared":false,"valuePrefix":"","valueSuffix":""},"legend":{"enabled":true,"backgroundColor":"","title":{"text":""},"layout":"horizontal","align":"center","verticalAlign":"bottom","borderWidth":"0","borderColor":"","borderRadius":"0"},"exporting":{"enabled":false,"chartOptions":{"plotOptions":{"series":{"dataLabels":{"enabled":false}}}},"filename":"","width":"","buttons":{"contextButton":{"align":"right","verticalAlign":"top","symbolStroke":"#666","text":""}}},"credits":{"enabled":true,"href":"https:\/\/market.us\/","text":"\u00a9 Market.us 2022"}},"type":"highcharts_basic_column_chart","height":"400"}, engine: "highcharts", type: "highcharts_basic_column_chart", title: "World Pharmaceutical Market Growth By Region 2021-2025", container: "wpDataChart_525", follow_filtering: 0, wpdatatable_id: 618, group_chart: 0}. While a lower ratio points towards the companys overburdened debt expenditures. They also need to work with regulatory agencies to ensure that this is safe for patients. Teva Pharmaceutical Industries Current Ratio 2010-2022 | TEVA. This is an important industry benchmark to show how much the company compensates the officers when compared to its competitors. ISIN: | SECTOR: Hospitals & Medical ServicesHospitals & Medical Services, Buy Healthcare Global Enterprises; target of Rs 310: Edelweiss, Narayana Hrudayalaya to acquire 100% stake in NewRise Healthcare, Poly Medicure: Outcome of committee meeting, Fortis Malar Hospitals' unsecured creditors meeting on April 26, 2017, Fortis Healthcare Q3 net profit at Rs 453.29 cr, Apollo Hospitals Q3 net dips 40% to Rs 73 cr, Poly Medicure gains 12%, to consider bonus issue on February 6, Fortis Healthcare Q2 net profit dips 37% to Rs 38 cr, Fortis Q3 PAT may dip 2.1% to Rs 42.8 cr: ICICI Securities, Apollo Hospitals Q1 PAT seen down 8.8% to Rs 69 cr: Edelweiss, Apollo Hospital Q2 profit may rise 7% to Rs 92.87 cr: Poll, Apollo Hospitals Q1 PAT may rise 9% to Rs 76 cr: Poll, Hits & misses in Q3: Rajesh Jain analyses 4 stocks. The annual growth rate has a CAGR of 1.8%. This is due to factors such as the aging population or the imminent expiration of patent medicines. The best of the best: the portal for top lists & rankings: Strategy and business building for the data-driven economy: Pharmaceutical market: worldwide revenue 2001-2022, Global pharmaceutical market - revenue distribution 2010-2021, by region, Top therapeutic classes by global pharmaceutical sales 2018 estimates, Total global pharmaceutical R&D spending 2014-2028, Number of novel drugs approved annually by CDER 2008-2022, Revenue of the worldwide pharmaceutical market from 2001 to 2022 (in billion U.S. dollars), World pharmaceutical sales 2017-2021 by region, Global pharmaceutical sales from 2017 to 2021, by region* (in billion U.S. dollars), World pharmaceutical market distribution by submarket 2014-2021, Distribution of the total global pharmaceutical market sales from 2014 to 2021, by submarket*, Revenues of top 10 global pharmaceutical markets 2021, Revenues of top 10 national pharmaceutical markets worldwide in 2021 (in billion U.S. dollars), Top pharmaceutical products by sales worldwide 2021, Leading pharmaceutical products by sales worldwide in 2021 (in billion U.S. dollars), Share of pharmaceutical value worldwide 2021, by country, Value share of the pharmaceutical market worldwide as of November 2021, by country*, Value share of pharmaceutical subsectors worldwide 2003 vs. 2021, Value share of the pharmaceutical market worldwide in 2003 and 2021, by subsector*, Top therapy classes by spending global market 2026 forecast, Projected top therapy areas worldwide in 2026, by spending (in billion U.S. dollars), Global pharmaceutical revenue by technology 2012-2026, Global pharmaceutical revenue distributed by technology from 2012 to 2026 (in billion U.S. dollars), Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026, Prescription drugs sales worldwide excluding generics and orphan drugs from 2012 to 2026 (in billion U.S. dollars), Projection of global revenue for orphan prescription drugs 2012-2026, Global prescription orphan drug sales from 2012 to 2026 (in billion U.S. dollars), Worldwide generic prescription drug sales 2012-2026, Worldwide generic prescription drug sales from 2012 to 2026 (in billion U.S. dollars), Revenue of the global OTC pharmaceutical market 2016-2027, Revenue of the global OTC pharmaceutical market from 2016 to 2027 (in billion U.S. dollars), Global oncology spending from 2011 to 2023 (in billion U.S. dollars), Tota pharmaceutical value worldwide 2021, by subsector, Total pharmaceutical value worldwide as of November 2021, by subsector* (in million U.S. dollars), Top 50 pharmaceutical companies - Rx sales and R&D spending 2021, Leading 50 global pharmaceutical companies by prescription sales and R&D spending in 2021 (in billion U.S. dollars), Global Rx drug market share by top companies 2019 and 2026, Top 20 pharmaceutical companies worldwide based on prescription drug market share in 2019 and 2026*, Top 10 biotech and pharmaceutical companies based on market cap 2022, Leading 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2022 (in billion U.S. dollars), Pfizer's total revenue from 2006 to 2021 (in million U.S. dollars), Novartis AG's total revenue from 2007 to 2022 (in billion U.S. dollars), Total sales of the Roche Group from 2006 to 2022 (in million Swiss francs), Johnson & Johnson's total sales 2005-2022, Johnson & Johnson's total sales from 2005 to 2022 (in million U.S. dollars), Projected top pharmaceutical companies based on new sales 2023, Leading pharmaceutical companies worldwide based on projected sales increase during 2023 (in billion U.S. dollars), Total global spending on pharmaceutical research and development from 2014 to 2028 (in billion U.S. dollars), Global top pharmaceutical companies based on R&D spending 2026, Global top 10 pharmaceutical companies based on projected R&D spending in 2026 (in billion U.S. dollars), Patent expiration risks for total worldwide prescription drug revenue 2020-2028, Worldwide total prescription drug revenue at risk from patent expiration from 2020 to 2028 (in billion U.S. dollars), Worldwide prescription drug revenue - market risk from patent expiration 2020-2028, Share of global prescription drug revenue at risk from patent expiration from 2020 to 2028, Pharmaceutical industry - number of new substances 1998-2021, Number of new chemical or biological entities developed between 1998 and 2021, by region of origin, Pharma companies worldwide with active R&D pipelines 2001-2022, Total number of pharmaceutical companies with active R&D pipelines worldwide from 2001 to 2022, Total number of novel drugs approved by CDER from 2008 to 2022, Projected most valuable R&D projects based on net present value 2022, Selected top pharmaceutical R&D projects based on net present value (NPV) as of December 2022 (in billion U.S. dollars), World pharmaceutical sales by region forecast 2025, Projected global pharmaceutical sales for 2025, by region* (in billion U.S. dollars), Global spending on medicines in 2010, 2021, and a forecast for 2026 (in billion U.S. dollars), CAGR by product type in pharmaceutical markets forecast 2022-2026, Projected pharmaceutical spending CAGR worldwide between 2022 and 2026, by market and product type, Country comparison in spending on medicine 2026, Projected spending on medicine of selected countries worldwide in 2026 (in billion U.S. dollars), Leading global pharmaceutical products by projected sales 2026, Projected top 10 global pharmaceutical products by sales in 2026 (in million U.S. dollars), Top global biopharma drugs by lifetime sales up to 2026, Projected top 10 pharmaceutical products worldwide based on lifetime sales as of 2026 (in billion U.S. dollars), COVID-19 vaccine dose numbers by top manufacturer 2021, Drug manufacturers with the highest number of ordered COVID-19 vaccine doses as of March 2021* (in million doses), Top companies by COVID-19 treatment vaccines in development June 2022, Leading companies by number of COVID-19 drugs and vaccines in development as of June 3, 2022, Number of COVID-19 drugs in development worldwide by phase June 2022, Number of coronavirus (COVID-19) drugs and vaccines in development worldwide as of June 3, 2022, by phase, BARDA funding for the development of COVID-19 vaccines in the U.S. 2021, BARDA funding for the development of COVID-19 vaccines in the United States as of March 2021* (in million U.S. dollars), Forecasted sales of select COVID-19 vaccines worldwide 2021-2022, Forecasted sales of select COVID-19 vaccines worldwide in 2021 and 2022 (in billion U.S. dollars), Gilead Science's remdesivir manufacturing projections 2020, Cumulative amount of remdesivir treatment courses projected to be manufactured by Gilead Sciences during 2020 (in 1,000s), Global mRNA vaccines and therapeutics market for COVID-19 Q4 2020 vs. 2025, Global mRNA vaccines and therapeutics market for COVID-19 in Q4 2020 and a forecast for Q4 2025 (in million U.S. dollars).